Evgen Pharma Plc (LON:EVG) is the topic of conversation when Vadim Alexandre, Head of Research at Northland Capital Partners joins DirectorsTalk. With Evgen proving it’s interim results and notice of..
Headlam Group plc (LON:HEAD) is the topic of conversation when Zeus Capital’s Equity Research Director Andy Hanson caught up with DirectorsTalk for an exclusive interview Q1: Headlam Group made..
Tatton Asset Management PLC (LON:TAM) is the topic of conversation when Zeus Capital’s Research Director Robin Savage caught up with DirectorsTalk for an exclusive interview Q1: Now, Tatton Asset..
Evgen Pharma plc (LON:EVG), the clinical stage drug development company focused on cancer and neurological conditions, announces its unaudited interim results for the six months ended 30 September 2017. Highlights..
Bluejay Mining plc ORD 0.01P, (LON:JAY) the AIM and FSE listed company with projects in Greenland and Finland, is pleased to announce that it has completed its maiden 2017 field..
